학술논문
MAP17 predicts sensitivity to platinum-based therapy, EGFR inhibitors and the proteasome inhibitor bortezomib in lung adenocarcinoma
Document Type
Article
Author
Source
In: Journal of Experimental and Clinical Cancer Research . (Journal of Experimental and Clinical Cancer Research, 17 August 2018, 37(1))
Subject
Language
English
ISSN
17569966